Comment
. 2010 Nov 1;28(31):e649-50; author reply e651-3.
doi: 10.1200/JCO.2010.31.3254.
Epub 2010 Sep 20.
Randomized phase II trials: misleading and unreliable
- PMID: 20855829
- DOI: 10.1200/JCO.2010.31.3254
Item in Clipboard
Comment
Randomized phase II trials: misleading and unreliable
J Clin Oncol.
.
No abstract available
Comment on
-
Randomized phase II trials: inevitable or inadvisable?J Clin Oncol. 2010 May 20;28(15):2641-7. doi: 10.1200/JCO.2009.26.3343. Epub 2010 Apr 20. J Clin Oncol. 2010. PMID: 20406933 No abstract available.
Similar articles
-
Examining heterogeneity in phase II trial designs may improve success in phase III.J Natl Cancer Inst. 2008 Feb 6;100(3):164-6. doi: 10.1093/jnci/djn006. Epub 2008 Jan 29. J Natl Cancer Inst. 2008. PMID: 18230788 No abstract available.
-
Criticism of tumor response criteria raises trial design questions.J Natl Cancer Inst. 2006 Feb 15;98(4):232-4. doi: 10.1093/jnci/djj086. J Natl Cancer Inst. 2006. PMID: 16478740 No abstract available.
-
[Methodological approaches of clinical studies with targeted therapies].Bull Cancer. 2008 Feb;95(2):185-90. doi: 10.1684/bdc.2008.0575. Bull Cancer. 2008. PMID: 18304903 Review. French.
-
Developing drugs that do not cause tumor regression.Clin Adv Hematol Oncol. 2003 Nov;1(11):654-5. Clin Adv Hematol Oncol. 2003. PMID: 16258462 No abstract available.
-
A strategic framework for novel drug development in multiple myeloma.Br J Haematol. 2007 Jul;138(2):153-9. doi: 10.1111/j.1365-2141.2007.06641.x. Br J Haematol. 2007. PMID: 17593022 Review. No abstract available.
Cited by
-
Randomized phase II trials: a long-term investment with promising returns.J Natl Cancer Inst. 2011 Jul 20;103(14):1093-100. doi: 10.1093/jnci/djr218. Epub 2011 Jun 27. J Natl Cancer Inst. 2011. PMID: 21709274 Free PMC article. Review.
-
Latest developments in the treatment of melanoma: 'a penicillin moment for cancer'?J R Soc Med. 2011 Jun;104(6):269-72. doi: 10.1258/jrsm.2011.100405. J R Soc Med. 2011. PMID: 21659402 Free PMC article. No abstract available.
-
More randomization in phase II trials: necessary but not sufficient.J Natl Cancer Inst. 2011 Jul 20;103(14):1075-7. doi: 10.1093/jnci/djr238. Epub 2011 Jun 27. J Natl Cancer Inst. 2011. PMID: 21709273 Free PMC article. No abstract available.
-
An Overview of Phase 2 Clinical Trial Designs.Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):22-29. doi: 10.1016/j.ijrobp.2021.07.1700. Epub 2021 Aug 4. Int J Radiat Oncol Biol Phys. 2022. PMID: 34363901 Free PMC article. Review.
-
Designing phase II trials in cancer: a systematic review and guidance.Br J Cancer. 2011 Jul 12;105(2):194-9. doi: 10.1038/bjc.2011.235. Epub 2011 Jun 28. Br J Cancer. 2011. PMID: 21712822 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
